Abstract
Background: The use of light for its antidepressant action dates back to the beginnings of civilization. Three decades ago, the use of bright-light therapy (BLT) for treating Seasonal Affective Disorder (SAD) was officially proposed. Since then, a growing scientific literature reports its antidepressant efficacy in both unipolar and bipolar disorders (BD), with or without seasonal patterns. This review aims to examine the management of BLT as a personalized and precision treatment in SAD, unipolar, and BD.Methods: We conducted a narrative review using Medline and Google Scholar databases up to June 2018.Results: BLT has physiological effects by resynchronizing the biological clock (circadian system), enhancing alertness, increasing sleep pressure (homeostatic system), and acting on serotonin, and other monoaminergic pathways. Effects of BLT on mood depend on several factors such as light intensity, wavelength spectrum, illumination duration, time of the day, and individual circadian rhythms. A growing body of evidence has been generated over the last decade about BLT evolving as an effective depression treatment not only to be used in SAD, but also in non-seasonal depression, with efficiency comparable to fluoxetine, and possibly more robust in patients with BD. The antidepressant action of BLT is fast (within 1-week) and safe, with the need in BD to protect against manic switch with mood stabilizers. Side effects might be nausea, diarrhea, headache, and eye irritation, and are generally mild and rare. This good safety profile may be of particular interest, especially in women during the perinatal period or for the elderly. The management of BLT needs to be clarified across mood disorders and future studies are expected to compare different dose-titration protocols, to validate its use as a maintenance treatment, and also to identify predictive biomarkers of response and tolerability. We propose clinical guidelines for BLT use in SAD, non-seasonal depression, and BD.Conclusions : BLT is an efficient antidepressant strategy in mono- or adjunct-therapy, that should be personalized according the unipolar or bipolar subtype, the presence or absence of seasonal patterns, and also regarding its efficacy and tolerability.
Highlights
The use of light for its antidepressant action dates back to the beginnings of civilization [1]
This review aims to examine the management of bright-light therapy (BLT) as a personalized and precision mood disorders treatment, encompassing both unipolar and bipolar disorders, and seasonal and non-seasonal characteristics
We decided to divide literature results in four main sections: [1] BLT in Seasonal Affective Disorder (SAD); [2] BLT in non-seasonal depression; [3] BLT in bipolar disorders (BD) depression; [4] BLT for sleep and circadian rhythms abnormalities associated in chronic mood disorders
Summary
The use of light for its antidepressant action dates back to the beginnings of civilization [1]. Light exerts strong effects on mood thanks to many circadian and non-circadian actions that may combine: phase shifting of circadian rhythms, enhancement alertness, sleep homeostasis by increasing EEG delta activity and sleep pressure, and modulation of the serotonin and other monoaminergic pathways. These effects of BLT on mood depend on several factors such as light intensity, wavelength spectrum, illumination duration, time of the day, and individual circadian rhythms [3]. This review aims to examine the management of BLT as a personalized and precision treatment in SAD, unipolar, and BD
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have